Regulations.gov document
Purpose and Content of Use-Related Risk Analyses for Drugs, Biological Products and…
Other · FDA-2024-D-2484 · posted Jul 9, 2024
Key facts
| Document ID | FDA-2024-D-2484-0002 |
|---|---|
| Title | Purpose and Content of Use-Related Risk Analyses for Drugs, Biological Products and Combination Products; Draft Guidance for Industry and Food and Drug Administration Staff |
| Document type | Other |
| Subtype | Guidance |
| Agency | FDA |
| Docket | FDA-2024-D-2484 |
| Posted | Jul 9, 2024 |
| Comment period opens | Jul 9, 2024 |
| Comments due | Sep 10, 2024 |
At a glance
- No Open for comment
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: